Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Nephrotic Syndrome in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
YASEMİN AYDIN KARTAL
Phramongkutklao College of Medicine and Hospital
Sichuan Haisco Pharmaceutical Group Co., Ltd
Alessandra Palo
Axon Neuroscience SE
Gregorio Covino
Saint Pierre Institute - Palavas les Flots
Erzurum Regional Training & Research Hospital
Eastman Kodak Company
CeRSM
Grünenthal Denmark ApS
Department of Anesthesiology, North Denmark Regional Hospital
Irish Endocrine Society
Aga Khan Foundation, Pakistan
Outpatient Endovascular and Interventional Society
Invicta Medical Inc.
EMET Pharmaceuticals, LLC
Doterra Healing Hands Foundation
CARITAS Rundum zu Hause betreut
Yancheng City NO.1 People's Hospital
View Full List
Medical Conditions
Lip and Oral Cavity Cancer
Shoulder Arthropathy
MEK Inhibitor-Associated Serous Retinopathy
Fibromyoma;Cervix
Canaloplasty
Animal-assisted Intervention
Etomidate Overdose of Undetermined Intent
Chemotherapy-induced Febrile Neutropenia (FN)
Retroperitoneal Disease
Active Cocaine Users
Joint Arthroplasty
Corticobasal Degeneration
Blood Sampling
Contingent Versus Noncontingent Incentives
Adult Myxopapillary Ependymoma
Documented Silent Ischemia
Refractory Malignant Skin Neoplasm
B-cell Acute Lymphoblastic Leukemia
Desquamative Interstitial Pneumonia
Cough Variant Asthma
View Full List
Drug Interventions
Anti-PD1 antibody, nimotuzumab and capecitabine
Enteral oxygen therapy
Systemic intravenous lidocaine infusion
MYL-1501D product using manufacture process VI
Carbetocin
LY2216684
Ranitidine
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
Neridronate
Lenalidomide
Leuprolide acetate 11.25 mg
Risperidone
Amantadine Sulfate
Pregabalin
Test varnish
Betamethasone
Pacritinib
Niraparib
Apatinib
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Belgium
Contract Research Organizations in Bulgaria
Contract Research Organizations in Congo
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Denmark
Contract Research Organizations in Djibouti
Contract Research Organizations in Finland
Contract Research Organizations in Gabon
Contract Research Organizations in Madagascar
Contract Research Organizations in United Kingdom
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Gambia
SGS
All CROs in Gambia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe